Darrin Uecker, Chief Technology Officer
Professional Overview
Darrin Uecker is a seasoned technology executive with over 15 years of experience driving innovation and operational excellence in the healthcare and medical technology industries. As the Chief Technology Officer of Pulse Biosciences, Inc., he is responsible for leading the company's research, development, and engineering efforts to advance their novel cellular delivery platform for the treatment of a wide range of diseases.
Experience Summary
Current Role
As the Chief Technology Officer of Pulse Biosciences, Inc. since 2022, Darrin is spearheading the development and commercialization of the company's proprietary Nano-Pulse Stimulation (NPS) technology. In this role, he oversees a team of scientists and engineers focused on expanding the applications of NPS in areas such as oncology, dermatology, and urology. Under his technical leadership, Pulse Biosciences has made significant strides in optimizing the performance and scalability of their platform, positioning the company as a leading innovator in the field of cellular therapies.
Career Progression
Prior to his current role, Darrin served as the President and CEO of Pulse Biosciences from 2015 to 2022, where he guided the company through its initial public offering and established strategic partnerships to accelerate the development and commercialization of their technology. Before Pulse Biosciences, he held executive positions at other prominent medical technology companies, including Progyny (formerly Auxogyn, Inc.), Gynesonics, Inc., and CyberHeart, where he demonstrated his ability to drive product innovation, operational efficiency, and commercial success.
Academic Background
Darrin holds a Master of Science degree in Mechanical Engineering from the University of California, Berkeley, with a focus on biomechanics and biomedical engineering. His strong technical background, combined with his extensive industry experience, has equipped him with the necessary skills to lead complex R&D initiatives and translate cutting-edge research into practical solutions for patients.
Areas of Expertise
- Cellular therapies and tissue engineering
- Biomedical device design and development
- Nano-scale technology and electrical stimulation
- Clinical research and regulatory affairs
- Strategic leadership and business development
Professional Impact
Under Darrin's technical guidance, Pulse Biosciences has achieved several notable milestones, including the successful completion of multiple clinical trials, the expansion of their intellectual property portfolio, and the securing of key regulatory approvals for their NPS technology. His contributions have been instrumental in positioning the company as a leader in the field of non-thermal cellular therapies, with the potential to revolutionize the treatment of various medical conditions.
Conclusion
With his deep technical expertise, strategic vision, and proven track record of driving innovation in the healthcare industry, Darrin Uecker is well-positioned to continue leading Pulse Biosciences' efforts to unlock the full potential of their transformative cellular delivery platform. His commitment to advancing the field of biomedical engineering and improving patient outcomes makes him a valuable asset to the company and the broader medical technology ecosystem.
